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The adipose tissue was considered a reserve of energy until the ’80s, when it was found that this tissue was
involved in the metabolism of sex steroids such as estrogens. From then on, the importance attributed to this
tissue radically changed as it was then considered an active organ, involved in important functions of the human
body. In 2001, for the first time, the existence of stem cells within this tissue was reported, and since then, this
tissue has been gaining an increased importance as a stem cell source for a wide range of potential applications
in cell therapies and=or tissue engineering and regenerative medicine strategies, mainly due to its wide avail-
ability and easy access. This manuscript provides an overview on adipose stem cells (i.e., adipose tissue–derived
stem cells, ASCs) considering the tissue of origin, the niche of the ASCs, and their phenotype in all aspects. In
this paper it is also discussed the markers that have been used for the characterization of these cells, their
differentiation properties, and their immunological reactivity, reporting studies from 2001 until this date. The
ASCs are also compared with bone marrow stem cells (BMSCs), until now considered as the gold standard
source of stem cells, underlining the common characteristics and the differences between the stem cells obtained
from these two sources, as well as the advantages and disadvantages of their potential use in different appli-
cations. Finally, this review will also focus on the potential application of ASCs in tissue engineering applica-
tions, particularly in the regeneration of bone and cartilage, commenting on the progress of this approach and
future trends of the field.
Introduction
Tissue engineering and regenerative medicine ap-proaches offer the possibility to help in the regeneration of
tissues damaged by disease or trauma.1,2 This is achieved
through the use of degradable biomaterials that serve as tem-
porary scaffold for transplanted cells to attach, grow, and
maintain differentiated functions.2 Therefore, a major consid-
eration for the most widely studied tissue engineering ap-
proaches, which are based on seeding and in vitro culturing of
cells within the scaffold before implantation, is the cell source
and the ability to control cell proliferation and differentiation.
The recent identification of human embryonic stem cells—cells
that can give rise to essentially all cell types in the body, de-
pending on the culturing conditions—offers probably the most
exciting alternative source of cells for tissue engineering.
However, researchers are still far from being able to control the
differentiation of embryonic stem cells in culture. In addition,
the research on embryonic cells brings up a range of ethical,
political, and legislative problems that differ from country to
country.3,4 This has driven researchers to actively investigate
alternative cell sources, such as the adult stem cells. These are
undifferentiated cells that occur in differentiated tissues theo-
retically in the adult body but in fact from birth. They can
renew themselves in the body, making identical copies of
themselves for the lifetime of the organism, or become spe-
cialized to yield the cell types of the tissue of origin. Thus, they
are presently considered as multipotent stem cells.5,6 Now,
several sources of adult stem cells have been identified, but
bone marrow has been the most widely studied for bone tis-
sue engineering applications.7–14 Bone marrow stem cells
(BMSCs) consist of a heterogeneous cell population, also
known as mesenchymal stem cells, that contributes to the
generation of mesenchymal tissue such as bone, cartilage, and
muscle. Bone marrow has also been considered a main source
of stem cells for therapeutic purposes, as it has high differen-
tiation potentials and low morbidity during harvesting.
However, for example, the osteoprogenitor population tends to
decrease in aged and osteoporotic humans. Also, excessive
proliferation in vitrowould decrease their osteogenic potential.
Because a high cell density is required to yield a successful
outcome of tissue-engineered bone, an alternative source of
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adult stem cells that could be obtained in larger quantities,
under local anesthesia and with minimal discomfort, would be
advantageous. Recent studies indicated that nascent stem cells
exist within other adult tissues, such as the adipose tissue. In
fact, it has been demonstrated that adipose tissue–derived stem
cells (ASCs) possess multiple differentiation capacities.5 Ad-
ditionally, adipose tissue is probably the most abundant and
accessible source of adult stem cells, and thus it holds great
promise for use in tissue repair and regeneration. Nevertheless,
ASCs and marrow-derived stem cells are remarkably similar
with respect to growth and morphology, displaying fibro-
blastic characteristics, with abundant endoplasmic reticulum
and large nucleus relative to the cytoplasmic volume.5,15,16
Other common characteristics of ATSCs and BMSCs can be
found in the transcriptional and cell surface profile. In fact,
much of the research carried out so far with ASCs has been
based on methods previously established for BMSCs.5,15,16
Nevertheless, to take full advantage of this cell source for tissue
engineering applications, it is necessary to learn more about
this cell source and understand its specific characteristics,
which will certainly indicate that future research on this cell
source will need to address several issues, such as, the differ-
ences found in the harvesting methods, differences in fat tissue
derived from different anatomic sites (e.g., abdomen, thighs,
infrapatellar, visceral, and subcutaneous), and the heteroge-
neity of the cell population that is obtained using the isolation
methods most commonly used do far. This manuscript provi-
des an overview on these aspects, focusing on the potential of
ASC in bone and cartilage tissue engineering.
Main Aspects of Adipose Tissue Physiology
The adipose tissue is composed of cells—the adipocytes—
organized in multidepots.17,18 However, only one-third of
the adipose tissue contains adipocytes, the remaining tissue
being composed of small blood vessel, nerve tissue, fibro-
blasts, preadipocytes, and adult stem cells.3 The adipocytes
can be white or brown, defining the type of the adipose
tissue as white adipose tissue (WAT) or brown adipose tissue
(BAT), respectively.17 The WAT is characterized by an ivory=
yellow color, while the BAT appears brown. In neonates, the
BAT can be found in several parts of the body19–21; however,
with aging, brown adipocytes undergo a morphologic
transformation, which is characterized by an accumulation of
lipids; the brown adipocytes become unilocular and lose the
ultrastructural and molecular proprieties that define
them.22,23 As a consequence, it is not possible to find discrete
collections of this type of adipose tissue in adults.
The development of white adipocytes begins in the em-
bryonic stage,24 but it is only after the birth that the majority
of the differentiation process occurs.25 The WAT can be
found in several anatomic depots, but there are two main
anatomic subdivisions, each with unique metabolic, en-
docrine, paracrine, and autocrine properties: the intra-
abdominal or visceral adipose tissue and the subcutaneous
adipose tissue. The subcutaneous adipose tissue is divided in
two different layers: the superficial subcutaneous adipose
tissue and the deep subcutaneous adipose tissue.26 The vis-
ceral fat is divided into intraperitoneal and retroperitoneal
adipose tissue. The intraperitoneal fat comprises the majority
of the visceral fat.27–29 WAT depots have also been found
around other organs, such as the heart, kidney, and genitalia,
and bone marrow.17 It is particularly important to underline
that the metabolic characteristics of each type of depot are
deeply influenced by the anatomic part where they are
found, and therefore, BAT and WAT may differ significantly
depending on the anatomical parts of origin.
The most well-known adipocytokine is leptin. Leptin has a
wide spectrum of endocrine and paracrine functions such
as appetite regulation, modulation of hepatic and adipose
tissue–related insulin secretion and activity, and modulation
of steroid in the ovaries and adrenal cortex.30 Other impor-
tant adipocytokines include adipsin, adiponectin, and tumor
necrosis factor-a.31–33
Stem Cells from Adipose Tissue
Historical perspective of ASCs
Zuk et al.34,35 were the first to report the presence of stem
cells in the adipose tissue (i.e., the ASCs), publishing two
important papers between 2001 and 2003, the first demon-
strating the differentiation potential of these cells34 and the
second one showing the presence of all the proteins recog-
nized as markers for the stem cells.34,35 However, even
though Zuk was the first one to formally describe these cells
from the adipose tissue as stem cells, previous reports
demonstrated the capability of preadipocytes to exhibit an
osteogenic potential.36–38
After the studies published by Zuk, several further pub-
lications,5,15,39–44 resulting from research carried out by dif-
ferent groups, showed the differentiation potential of the
ASCs and described the presence=absence of several mark-
ers. Nowadays, it has been described the extraction of ASCs
from multiple species, including rats, rabbit,45,46 dogs,47–49
pigs,50–53 and of course humans,54,55 as well as the capacity
of these cells to differentiate into the osteogenic,16,53,56–65
chondrogenic,16,61,62,66–70 myogenic,71,72 neuronal,52,73,74 and
even cardiomyocytic lineages75,76 (Table 1).
The nomenclature is part of the history of these stem cells.
As it happens frequently in rapidly developing scientific
fields, stem cells from adipose tissue have been named with a
very wide variety of terms. The cells isolated from the di-
gestion of the adipose tissue with collagenase have been
termed adipose stem=stromal cells (ASCs), adipose-derived
adult stem (ADAS) cells, adipose-derived stromal cells
(ADSCs), adipose mesenchymal stem cells (AdMSCs), pro-
cessed lipoaspirated cells (PLA), and preadipocytes. The use
of multiple nomenclatures obviously created confusion
within this research field. Finally, the researchers who par-
ticipated in the annual conference of the International Fat
Applied Technology Society, held in Pittsburgh in 2004, have
reached a consensus, adopting the designation of adipose
stem cells (ASCs).
Localization of ASC in fat tissue
As mentioned before, there are several adipose depots all
around the body, and each one situated in a specific niche.
As a consequence, the ASCs isolated from one depot can
differ from the ones isolated from other depot located in a
different anatomical areas, as well as the cells isolated from
WAT can have different characteristics with respect to the
ones isolated from brown adipose tissue. The WAT and the
BAT differ in the number of ASCs that can be isolated and in
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the phenotypes that they can originate.17 In fact, the number
of adult stem cells that can be found in the WAT is higher
than that found in the brown adipose tissue, and the cells
from WAT grow faster than the cells isolated from BAT.77
Further, there are significant differences in the surface
markers found in stem cells obtained from white or brown
adipose tissue, which suggests the possible existence of two
different stem cell populations, corresponding to cells iso-
lated from these two different types of fat tissue.17 The stem
cells isolated from BAT and WAT differ also in their differ-
entiation potential, as demonstrated by a study from Cas-
teilla and coworkers,78 where it is shown that when the stem
cells from these two different types of adipose tissue were
cultured with osteogenic medium, the cells isolated from
WAT exhibited a higher osteogenic differentiation potential.
In addition to the differences in the stem cells isolated
from WAT or BAT that have been macroscopically detected,
differences have also been found on ASCs isolated from
subcutaneous WAT with respect to those isolated from vis-
ceral WAT and also when different subcutaneous depots
were considered.46 Studies on ASCs isolated from visceral
and subcutaneous adipose tissue shown that stem cells iso-
lated from subcutaneous fat show a higher proliferation rate
but a lower differentiation capacity, especially regarding the
osteogenic differentiation as compared to the stem cells iso-
lated from visceral fat tissue.46,77 An interesting study from
Mochizuki et al.79 compares the chondrogenic differentiation
potential of human ASCs isolated from fibrous synovium,
adipose synovium, and subcutaneous fat, and, once again, it
shows that there are significant differences between the cells
Table 1. Animal Models and Enzymes Used for Adipose Stem Cell Isolations Described in Literature
Species of origin Location of origin Isolation procedure Differentiation Reference
Human Lipoaspirated
subcutaneus
Collagenase type I Adipogenic, chondrogenic,
osteogenic, and myogenic
34
Human Subcutaneus
adipose tissue
Collagenase type I Adipogenic and osteogenic 42
Human Lipoaspirated
subcutaneus
Collagenase type I None 43
Rabbit Visceral and subcutaneus
adipose tissue
Collagenase type I Osteogenic 47
Dog Inguinal fat pad Collagenase type I Osteogenic 49
Human Lipoaspirated 51
Human Tissue Collagenase Adipogenic 79
Mice Inguinal, epidydimal,
and brown adipose tissue
Collagenase type II Osteogenic 80
Human Adipose synovium
and subcutaneus
adipose tissue
Collagenase D Chondrogenic, adipogenic,
and osteogenic
81
Human Abdomen and hip
subcutaneus tissue
Collagenase Adipogenic osteogenic 82
Pig Subcutaneus adipose tissue Collagenase type I Myogenic 52
Piglet Facial or abdominal fat Collagenase type XI Adipogenic, chondrogenic,
osteogenic, and neurogenic
53
Human Lipoaspirated Collagenase Chondrogenic 63
Human Lipoaspirated Collagenase Cardiomyocytic lineage 77
Mice White subcutaneus
adipose tissue from
inguinal region
Collagenase type I Cardiomyocytic lineage 78
Human Lipoaspirated Collagenase type I Chondrogenic, adipogenic,
and osteogenic
87
Human Lipoaspirated Collagenase type I Adipogenic, chondrogenic,
and osteogenic
88
Human Subcutaneus liposuction Collagenase type I Chondrogenic 89
Human Subcutaneus liposuction Collagenase type I Osteogenic and lipogenic 90
Mice Lymph node adipose tissue Collagenase followed
by p75NTR-posive sorting
Adipogenic, osteogenic,
chondrogenic, and
neurogenic smooth
muscle cells lineage
92
Human Subcutaneus liposuction Collagenase followed
by serial centrifugations
Adipogenic, chondrogenic,
and cell lineage
91
Human Subcutaneus liposuction Collagenase followed
by serial centrifugations
Adipogenic and chondrogenic 91
Human Liposuction Collagenase followed
by immunomagnetic beads
cell purification for
CD34þ=CD31"
Lipogenic 93
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isolated from the different sites. The cells isolated from
fibrous synovium and fat synovium show the highest
chondrogenic and osteogenic differentiation potentials and
simultaneously the best results regarding the CFU-test than
the human ASCs isolated from subcutaneous fat tissue.
There are differences in the ASC population even when
the cells are isolated from the same type of adipose tissue but
from two different anatomical regions, as demonstrated, for
example, in a study by Wheeler and coworkers,80 which
shows that the ASCs isolated from the subcutaneous fat
tissue harvested from the hip have a higher osteogenic po-
tential than ASCs harvested from the abdomen.
Methods for the isolation of ASCs
The first isolation method of cells from the adipose stro-
mal vascular fraction (SVF ) was optimized by the pioneer
Rodbell in the far ’60s.81–83 As mentioned before, Zuk and his
collaborators were the first to report on the existence of ASCs
in the fat tissue, in 2001.34 This group isolated the adult stem
cells from fat tissue using an enzymatic method, which is still
the basis of most methods used nowadays for this purpose,
followed by a natural selection of the cells based on the
propriety of ASCs to adhere to the plastic surface of tissue
culture flasks.41,42,54,56,80,84–88 The enzyme used is most of the
time collagenase type I varying in the concentration and in
the incubation time (Table 1).
So far, only a very small number of alternative isolation=
purification methods are found in the literature. One of these
alternative isolation procedures is described by Miyazaky
et al., who uses serial centrifugation to collect two distinct
phases and therefore isolated two different subpopulations,89
while Yamamoto et al.90 describes the use of cell sorting se-
lecting the p75 receptor–positive cells, after the enzymatic
isolation, and demonstrated the higher chondrogenic and
osteogenic differentiation potential of the p75-positive cells
than the p75-negative cells.
An elegant method to isolate CD34þ=CD31" cells from
SVF performing serial cell purification steps, using im-
munomagnetic beads, was developed by Sengenes et al.,91
who demonstrated that the cell population isolated exhibited
similar characteristics of adult mesenchymal stem cells. Also
Rada et al. isolated human ASCs using immunomagnetic
beads coated with several different antibodies (ab) markers
for these cells, and compared the stemness and osteogenic
and chondrogenic potential between the different subpopu-
lations isolated and with the ASCs isolated with the enzy-
matic method. The results obtained in this study underline
the complexity of the adipose tissue and ASCs where exist
several stem cell subpopulations, each one with a proper
marker expression and a proper differentiation potential.92
A study on the optimization of the classical isolation
method was published recently50 with the aim of establish-
ing the optimal centrifugation speed to isolate the highest
number of ASCs and, at the same time, to exclude other cell
types. The results obtained showed that the best centrifu-
gation speed is 1200 g, while when the gravity of the cen-
trifugation reached 3000 g, the ASCs are damaged.
Nevertheless, the examples reported above on alternative
methods for ASC isolations are still few and limited in terms
of the results produced. As described in the previous section,
the adipose tissue is a complex tissue composed of several
cell populations that adhere to the plastic surface of tissue
culture flasks, such as erythrocyte, endothelial cells, adipo-
cytes, neuron cells, adult stem cells, and fibroblasts. In ad-
dition, several studies show that fibroblasts inhibit the
osteogenic differentiation46 and that these particular cells
overgrow with respect to the remaining cell populations. For
all these reasons and because of the presence of several ASC
subpopulations in adipose tissue, it became obvious that
further efforts should be directed to establish a clear and
optimized isolation method that allows obtaining purified
ASC populations with specific characteristics, by enabling
the simultaneous isolation of these distinct ASC subpopula-
tions that are present in the adipose tissue.
Another critical aspect regarding the isolation of the ASCs
is related to the method used to harvest the adipose tissue.
Considering the human model, the ASCs can be isolated
from fat tissue wastes resulting from plastic=reconstructive
surgeries, and minced into small fragments. When the
starting point is the waste obtained from a liposuction pro-
cedure, the isolation method is simplified, as this procedure
generates finely minced tissue fragments that have a more
homogeneous and smaller volume than when a larger
amount of tissue is minced manually, allowing a more effi-
cient enzymatic digestion.3 A study by Fraser et al.80 has
shown that the lipoaspiration surgery does not affect the
ASCs, and apparently only the lipocytes are damaged, as
these are cells of bigger dimensions that are affected by the
mechanical stress applied during the liposuction.
Characterization of the phenotype of ASCs
Although several studies have been done to establish the
markers of the ASC phenotype, this issue is still quite con-
troversial. Table 2 summarizes the studies performed so far
referring to different markers’ expression of ASCs.
On the surface of ASCs, HLA-ABC, CD29, CD49e, CD51,
and CD90 markers have been found with highly consistent
patterns of expression.42 Other factors, such as CD49d, CD9,
CD34, CD105, and CD166, are present in human ASC but
with an expression level lower than 50%.41
The presence or absence of Stro-1 is particularly contro-
versial. In fact, there are studies that report the absence of
this marker in ASC cultures,41 and others that relate its
presence.35 The same happens regarding CD34 and CD106,
because Gronthos et al.41 found these markers in ASCs, while
Zuk et al.35 reports their absence, and for Katz et al. these
markers are absent or expressed only on a negligible number
of cells.42 These contradictory results may, however, be ex-
plained by the differences in marker antibodies sources and
detection methods used in the referred studies.3
The expression of CD166, CD90, CD73, CD44, and CD29
changes during the cell passages88: the expression level of
these markers increases, considering the ASCs from the SVF
from passage 0 (p0), to passage 1 (p1) and passage 2 (p2),
and becomes stable after passage p2.
The ASCs from human origin also express, in short-term
cultures, molecules that are typical of the embryonic phe-
notype, such as OCT-4, UTF-1, and Nodal,93 which are cru-
cial for the migration of embryonic precursors during
development and that are necessary to maintain the undif-
ferentiated status of embryonic stem cells in culture.93 In
addition, analysis of the human ASC markers has shown the
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expression of Snail2 (Slug), a molecule that is associated with
epithelial–mesenchymal transition in cancer metastasis.
This section clearly describes that the markers that have
been reported in different studies on the characterization of
ASCs are sometimes contradictory. In fact, several groups
are currently studying ASCs, but the appropriate markers for
the characterization of these cells are still far from being
consensual.
Differentiation potential of stem cells
isolated from adipose tissue
As it was mentioned in previous sections, the stem cells
from adipose tissue have the ability to differentiate into
several different cell types. It has been demonstrated that the
ASCs have a neurogenic differentiation potential,34,74,94 car-
diomyocyte and myocyte differentiation potential,72,75,76,95
endothelial cell differentiation potential,34,75 hepatocyte dif-
ferentiation potential,96,97 adipogenic differentiation poten-
tial,34,53,98 and of course osteogenic and chondrogenic
differentiation potential.35,61,65,69,79 In this review the authors
will focus particularly on the osteogenic and chondrogenic
differentiation.
A large number of studies carried out so
far3,5,16,34,35,53,63,65,99,100 indicate that ASCs undergo osteo-
genic differentiation within in 2–4 weeks of culture, when
using the same culturing conditions used for the osteogenic
differentiation of BMSCs. The mechanisms that drive the
ASCs into the osteoblast lineage are still not clear. Never-
theless, some transcription factors such as PPARg and Runx2
have been suggested to play a critical role in the commitment
of bipotent stem cells with the capacity to differentiate to the
osteoblastic or adipocyte phenotype.101 The role of the del-
taFosB has also been investigated, and the results obtained102
showed that the overexpression of this transcription factor
leads to an increased bone mass and decreased adipocyte
formation.
As expected, the medium composition is very important
in the induction of the osteogenic phenotype. Culturemedium
supplemented with dexamethasone and b-glycerolphosphate
induces the osteogenic differentiation of ASCs. In fact, it has
been demonstrated that ASCs cultured in the presence of
these supplements express gene characteristics of osteoblast-
like cells, such as Run-x, BMP-2, BMP4, BMP receptor I and
II, and PTH receptor16,35,36; under these same culturing
conditions, the ASCs are also able to form mineralized ma-
trix. In other works,34,103 1,25-dihydroxyvitamin D3 (VD) has
also been investigated as a differentiation factor. Apparently,
VD inhibits adipogenesis and enhances osteogenesis in the
SAM=P6 mice, which is correlated to a 50% of reduction of
PPARg mRNA expression and protein synthesis, a decreas-
ing of Oil Red positively stained cells and an induction of the
osteoblastogenic genes.101,104,105
For inducing the osteogenic differentiation of ASCs,
BMP-2 has also been used. In ASCs the presence of BMP-2
increases the expression of runx-2 and osteopontin, pro-
moting the osteogenic differentiation.106 Another particularly
important factor regarding the osteogenic differentiation of
ASCs is the growth and differentiation factor 5 (GDF-5),
which appears to be more effective than BMP-2 in the in-
duction of the osteogenic differentiation, and it also increases
the expression of vascular endothelial growth factor (VEGF ),
promoting the vascularization.107
As mentioned before, the ASCs can also differentiate into
chondrocytes and used in potential tissue engineering–based
approaches for the regeneration of cartilage defects. ASCs
can express the biochemical markers associated to the
chondrocyte phenotype,5,87,108 and when cultured with TGF-
b, ascorbate-2-phosphate, and dexamethasone, these cells
secrete the extracellular matrix proteins, collagen II, collagen
IV, and aggrecan, typically found in native cartilage.
Bioactive factors of the BMP family have also been used
for inducing the chondrogenic differentiation of ASCs. For
example, it was found that BMP-6 promotes the chondro-
genic differentiation while the BMP-7 induces the chondro-
genic differentiation only when present in high doses.106,109
One other factor that seems to induce the chondrogenic
differentiation is FGF-2,110 which is responsible for upregu-
lating the expression of sox-9, a key factor in the chondro-
genic differentiation.
A special mention has to be done regarding the ASCs’
endothelial differentiation potential; in fact, the differentia-
tion into this lineage is among the most recent findings re-
garding the research on the of ASCs’ differentiation
potential.111–113
Studies done on the cytokines expressed by ASC revealed
a production of angiopoietin-1, and specially of hepatocyte
growth factor and VEGF (the last two were at levels that
were bioactive)114,115; moreover, the presence of a stem cell
population expressing CD34116 in adipose tissue has been
Table 2. Marker Expression=Phenotype of Adipose Stem Cells
Cell type=cell origin Cell markers present Cell markers absent Reference
Human=liposuction HLA-ABC; CD29; CD49e; CD51;
CD90; CD49d; CD9; CD34;
CD105; CD166
HLA-DR; CD8a; CD11a; CD18;
CD41a; CD49f; CD62L; CD62P;
CD106; CD117; CD133; CD243;
ABCG2
43
Human=subcutaneus HLA-ABC; CD9; CD10; CD13;
CD29; CD34; CD44; CD49e;
CD49d; CD54; CD55; CD59;
CD105; CD146; CD166; CD106
HLA-DR; CD11a; CD11b; CD11c;
CD14; CD18; CD45; CD50;
CD56; STRO-1
42
Human=liposuction CD29; CD44; CD71; CD90;
CD105=SH2; SH3; STRO-1;
CD49d; CD13
CD31; CD34; CD45; CD14;
CD16; CD56; CD61; CD62e;
CD104; CD106
35
Human OCT-4; UTF-1; Snail2 (Slug) 94
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shown, and it has been shown that it is possible that this cell
population can contribute to the formation of the vessels due
to the potential for differentiating in endothelial cells.
Finally, Cao et al.112 published a study describing the
isolation of CD31", CD34", CD106", and FLK1þ ASC sub-
populations, which were able to express (in vitro) endothelial
markers when cultured with VEGFs, such as CD31, CD34,
CD144, and eNOS; the study also demonstrated that in vivo
ASCs can differentiate into endothelial cells that contribute
to neoangiogenesis in hind limb ischemia models.
Immunological reactivity of ASCs
The immunological behavior of ASCs has been described
in a recent study,117 but many mechanisms and their detailed
steps remain unclear. The ASCs were found to be negative
regarding the expression of the most important immuno-
logically relevant surface antigens, such as MHC-II, CD40,
CD40L, CD80, and CD86, and these cells also do not express
IL-10 and TGF-b, well-known inhibitor factors of lympho-
cytes118; further, after the in vitro osteogenic differentiation
of the ASCs, they remain negative for MHC-II, CD40,
CD40L, CD80, and CD86 and thus for important T- and B-
cell–costimulating surface antigen.117
Additionally, it was shown that the culture with allogenic
lymphocytes did not lead to any enhancement of ASC pro-
liferation, and when allogenical and activated lymphocytes
are exposed to ASCs, the proliferation of the lymphocytes is
inhibited.117 In summary, the ASCs are unable to incite a
response of allogenic lymphocytes in vitro, inhibiting allo-
genic lymphocytes proliferation induced by allogenic PBMCs
or mitogens. The inhibitory effect of the ASCs over lym-
phocytes proliferation was proportional to the number of
stem cells and to the time of contact between stem cells and
lymphocytes.118 However, despite the immunogenity prop-
erties described for ASCs, temporal changes have been de-
scribed in vitro: in fact, when the cells are freshly isolated,
they can elicit a T-cell proliferative response, decreasing the
immunogenic response in the earlier passages (P0 and P1),
which then disappears in later passages (P2–P4).119
Mesenchymal stem cell sources: bone marrow versus
adipose tissue
The bone marrow has been the most widely used source of
mesenchymal stem cells for tissue engineering and other cell-
based therapies.16 Like the bone marrow, adipose tissue is
also a mesodermally derived organ, and therefore it is quite
obvious that stem cells derived from these two tissue share
several characteristics, including the proliferative potential
and the ability to undergo multilineage differentiation.16
The surface markers of these two stem cell populations are
quite similar; in fact, both stem cell populations isolated from
the bone marrow (BMSCs) and from the adipose tissue
(ASCs) express CD105, STRO-1, and CD166, markers which
are typically used to identify cells with multilineage differ-
entiation potential. ASCs and BMSCs also express CD117,
the stem cell factor receptor, and also CD29, CD44, and
CD49e.3,5,16,42 However, the two cell populations differ in the
expression of CD54, for example, which has shown higher
levels of expression in ASCs than BMSCs; in addition, CD49d
is expressed only in the ASCs, while CD106 is expressed only
by BMSCs.16
Studies on the immunological proprieties of ASCs and
BMSCs117,118 demonstrated that ASCs are immunoprivileged
cells that may be therefore available for cell replacement
therapies in HLA-incompatible hosts, before and after oste-
ogenic differentiation in vitro since under both conditions,
these cell showed no expression of important immunologi-
cally relevant surface antigen such as MHC-II, CD40, CD40L,
and CD90.
ASCs and BMSCs can both differentiate into chondrocytes,
osteoblasts, adipocytes, hepatocytes, neuron-like cells, and
myocytes, but the differentiation potential is not always
identical. It is still not clear which of the two stem cell
populations has the highest chondrogenic differentiation
potential, because despite the number of studies that have
been carried on this subject, the results obtained are still
controversial. Earlier studies35,85,108,120 show that there is
no difference between ASCs and BMSCs regarding the
chondrogenic differentiation potential, while some recent
articles121,122 claim that the BMSCs show an higher chon-
drogenic differentiation potential demonstrated by an higher
expression of the genes correlated to the chondrogenic line-
age and a higher synthesis of glycosaminoglycans (GAGs).
However, the different results obtained might be explained
by the different culturing conditions, as well as many other
variability factors, such as the age of the donor. Finally, one
should also consider that ASCs may need a different me-
dium composition, that is, a different cocktail of growth
factors to achieve a complete chondrogenic differentiation,
because most studies performed with these cells are based on
the same culturing conditions used for the stem cells ob-
tained from the bone marrow.
In the same way, regarding the osteogenic differentiation,
there are also controversial results with respect to the com-
parison between ASC and BMSC differentiation poten-
tial.5,35,85 Recently, an article was published100 where several
differentiation pathways for ASCs and BMSCs were com-
pared. In the early osteogenesis process of ASCs and BMSCs,
even if osteomodulin (OMD) gene expression has been ob-
served in both the cell populations, only in BMSCs was
observed an increase of the expression during the differen-
tiation and always associated with the expression of apoli-
poprotein-D (APOD). The two cell populations have shown
also differences in other gene expression, always correlated
with osteogenic differentiation such as TIMP4, RGC32,
FOXO1A, and NR2F1, demonstrating that there are real
differences between ASCs and BMSCs.100 Even if the cause of
this difference in the gene expression could be imputed to the
culture condition or growth factor cocktail, the ASCs could
need different chemical stimuli considering the different
niche of the two cell population. It is also important to
highlight that none of these studies have considered the
demonstrated possibility of ASCs obtained from different
anatomical sites to have different responses to differentiation
and, therefore, to the gene expression.
Finally, in a study by Kim et al., the neovascularization
potential of BMSCs and ASCs was compared. This research
group investigated the capacity to promote neovasculariza-
tion in nude mice, showing that a better neovascularization
was observed with ASCs, in both the cases, that is, when the
neovascularization was induced by the transdifferentiation
of the cells into endothelial cells and by the release of VEGF
and bFGF.123
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Application of ASCs in Tissue Engineering Strategies
ASCs in bone tissue engineering
Several studies have already been done in the field of
bone tissue engineering using ASCs.64,124–126 In general, these
studies have demonstrated that stem cells obtained from the
adipose tissue exhibit good attachment properties to most of
the material surfaces and the capacity to differentiate into
osteoblastic- like cells in vitro and in vivo125,127 (Table 3).
Cowan et al.127 were the first to demonstrate that ASCs
maintain their osteogenic differentiation capacity also in vivo.
For that purpose, they used apatite-coated and noncoated
poly(dl-lactide-co-glicolide) (PLGA) scaffolds, implanted in
critical-size defects induced in mice for 12 weeks seeded and
cultured with ASCs. The ASCs were isolated from FBV mice
(a knockout mice), cultured until the confluence, and then
the cells were seeded in the scaffolds that were implanted in
a 4-mm-size defect, in the right parietal bone of adult FBV
mice. The results obtained showed that the ASC-coated
scaffold constructs were able to form new bone compared to
the noncoated PLGA scaffolds, where less bone formation
was found.
Peterson et al.124 have carried out a study using collagen-
ceramic carriers and ASCs transfected with the BMP-2 gene
implanted in nude mouse critical-size femoral defect. This
study showed that the carrier was able to deliver the cells to
the defect area and that, due to the effect of BMP-2, the ASCs
were forming new bone, and thus the femoral defect was
healed after 8 weeks of implantation.
In a study published in 2006, Hattori et al.128 compared the
osteogenic differentiation potential between human BMSCs
and ASCs using b-TCP scaffolds. The cell–scaffold constructs
were cultured in vitro for 2 weeks with osteogenic medium
and then implanted for 8 weeks in the back of nude mice.
The results achieved in this study showed that there is no
difference between BMSCs and ASCs regarding their osteo-
genic differentiation, and that the presence of either of these
cells was also enhancing the vascularization process.
Shen et al.126 studied the osteogenic differentiation of rat
ASCs seeded on a 3D scaffold obtained by sintering PLGA-
based microspheres and cultured in the presence of GDF-5.
The obtained results suggest that the cells treated with
GDF-5 were not able to adhere to the scaffold, but remain
viable and with the capacity to migrate, proliferate, and
subsequently undergo osteogenic differentiation.
Another study by Kakudo et al.129 on the osteogenic dif-
ferentiation of ASCs on collagen scaffolds with an honey-
comb-like structure has shown that the ASCs differentiate
into osteoblast-like cells and were able to produce matrix
and to express the characteristic genes of osteoblasts.
Finally, recently it has been shown that ASCs may stim-
ulate the vascularization process. In fact, Scherberich et al.130
demonstrated that ASCs cultured in vitro onto hydroxyapa-
tite scaffolds in a 3D perfusion system with endothelial
cells and also when transplanted into nude mice promote
the formation of blood vessels. The induction of vasculari-
zation by the ASCs can be caused by the production of
VEGF and other cytokine by the stem cells from adipose
tissue.112,113,115
Cartilage tissue engineering using ASCs
Several studies have shown the potential of ASCs in sev-
eral different cartilage tissue engineering approaches, dem-
onstrating the chondrogenic differentiation potential when
these cells are cultured using the typical aggregate culture
technique (pellet culture)69 and when they are seeded in
materials to be further cultured in vitro and=or implanted in
different animal models131–133 (Table 3).
A work published in 2004 by Awad et al.66 describes one
of the first studies on cartilage tissue engineering using
stem cells isolated from human adipose tissue. This re-
search group compared several different scaffolds based on
agarose, alginate, and gelatine as support materials for
hASC adhesion, proliferation, and chondrogenic differenti-
ation. It was concluded that these cells were able to differ-
entiate into chondrocyte when seeded=cultured into any
of the studied scaffolds, although differences were found in
the proliferation rate, indicating that the most appropriate
scaffold material for the cell growth was the one based on
gelatine.
Table 3. Studies Regarding the Use of Adipose Stem Cells in Bone and Cartilage Tissue Engineering
Applications Found in the Literature
Model Application Reference
Human ASCs in vitro Bone tissue engineering 66
Human ASCs in nude rats Bone tissue engineering 125
Human ASCs in vitro Bone tissue engineering 126
Rat ASCs in vitro Bone tissue engineering 127
Mouse ASCs in mice Bone tissue engineering 128
Human ASCs in nude mice Bone tissue engineering 129
Human ASCs in nude mice Bone tissue engineering 130
Human ASCs in nude mice Bone tissue engineering 131
Human ASCs in vitro Cartilage tissue engineering 71
Rabbit ASCs in vitro Cartilage tissue engineering 132
Human ASCs in nude mice Cartilage tissue engineering 134
Human ASCs in nude mice Cartilage tissue engineering 133
Human ASCs in vitro Cartilage tissue engineering 68
Human ASCs in vitro Cartilage tissue engineering 135
Rabbit ASCs in rabbit Cartilage tissue engineering 136
ASC, adipose stem cells.
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Betre et al.134 studied the ASCs’ chondrogenic differentia-
tion using elastin-like polypeptide as support matrices and
demonstrated that the stem cells can grow and express the
chondrogenic phenotype, namely, the expression of collagen
II, aggrecan, and sox9 even when cultured without the
supplemented media usually used to induce the chondro-
genic differentiation.
Wei et al.131 tested the use of a injectable scaffold based on
condroitin sulfate for the ASCs’ condrogenic differentiation.
The results showed good cell viability and growth and also
that the ASCs differentiate into chondrocyte-like cells pro-
ducing GAG.
Dragoo et al.135 studied the in vivo chondrogenic regener-
ation by implanting fibrin glue scaffolds seeded with ASCs
in rabbits for 8 weeks. At the end of the implantation period,
the ASCs were expressing aggrecan and collagen II, the cells
were synthesizing GAGs, and new cartilage formation was
observed.
Present situation and future trends
Since 2001, when the presence of stem cells in the adipose
tissue was definitely demonstrated, many studies have been
published on the subject, most of which concern the use of
this alternative stem cell source in tissue engineering and=or
regenerative medicine applications. Many studies have
demonstrated the differentiation potential, as well as other
necessary requirements that assign the designation of stem
cells to this cell population.
The number of articles regarding the application of ASCs
in the biomedical fields is impressive considering the youth
of the ASCs’ identification. However, by one side each article
regarding the ASCs stimulates more research and knowl-
edge development on ASCs, and by the other side this sort
of marathon that aims to demonstrate the high potential of
ASCs seems to be hazardous. In fact, too many pieces of
this puzzle are still hidden, concerning not only the funda-
mental and basic mechanisms behind ASC biology, but also
some practical issues, such as the most appropriate isolation
procedure or the location of the tissue of origin. The ex-
pression of several markers is still on discussion, the path-
ways and mechanisms that avoid an immunoresponse
related to ASCs are still unknown, and no long-term in vivo
experiment has been done until now to demonstrate the
in vivo functionality of these cells. Therefore, exploring the
applications of ASCs without having a profound knowledge
of the tool has become almost an impossible mission. Fur-
ther, recent articles136–138 show that the ASCs cultured in vitro
under normal culture conditions for an extended period of
time can transform into cancer cells, like it has been reported
for embryonic stem cell cultures. Considering that ASCs
express genes typical of the embryonic stem cells,93 it is
reasonable to suppose that ASCs have several common
characteristics of the embryonic stem cells, including a mu-
tagenic activity.
Finally, the discrepancy in the studies concerning the ex-
pression of some markers may be related to the different
culturing conditions, but it can also mean that the stem cells
from adipose tissue constitute a complex population con-
sisting in several cell subpopulations each one with specific
characteristics and potential; in fact, the presence of several
subpopulations is not a new discovery because in BMSCs the
isolation=purification of subpopulation with different dif-
ferentiation potential is well documented.139–141 However,
regarding ASCs, there are only a few articles that analyze
this hypothesis.91,113,116
Although the studies based on tissue engineering and re-
generative medicine therapies focused on the ASCs raise a
great hope to all the researchers working in this field, it is
important to realize that in the near future, more studies and
efforts to understand the biology of the ASCs are mandatory,
as only better and profound knowledge of these cells will
enable to develop useful, safe, and powerful applications of
ASCs in the biomedical field.
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